NCT00625573View on ClinicalTrials.gov

Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

March 31, 2009

Conditions
Colorectal Cancer
Interventions
DRUG

Abraxane

100mg/m2 every week X's 3

Trial Locations (1)

33140

Mount Sinai Medical Center, Miami Beach

Sponsors

Collaborators (1)

Celgene Corporation
All Listed Sponsors
collaborator

Celgene Corporation

INDUSTRY

lead

Mt. Sinai Medical Center, Miami

OTHER